Search
            
Join/Renew     Contact ONS     Terms of Use    FAQ 
HOME
CNE Central Clinical Practice
Membership
Patient Education
Publications
Research
About CNE Central
CNE Index
Conferences and Regional Programs
Evaluation Center
 
Prevention and Detection
Types of Cancer
Treatment
Symptom Management
 
Education Resources
Professional Topics

Untitled Document
ONS Profile

 

Disease Specific: Hematological Malignancies

Extra! Extra! Read all about it!
We invite you to review ONS's The Myeloma Messenger and its associated podcast. Read about the very latest in the care of patients with multiple myeloma! Listen to the associated pod cast! Improve the care that you deliver to your patients! Funded by an unrestricted educational grant from Millennium Pharmaceuticals, this series is packed with the kind of information you need to more effectively care for this complex patient population. Learn more!

What’s Blasting Off in CML?

Chronic myelogenous leukemia (CML) is a complex disease that occurs in about 1 in 100,000 people. This webcast will include an overview of the genetic disease development and its phases. Through the presentation of case studies, the participant will gain an improved comprehension of the progression of the disease, current and possible future treatments, and how to identify patients at increased risk for relapse. Learn more.

Unraveling the Mysteries of MDS—Linking Science to Practice through Case Studies

Myelodysplastic syndrome (MDS) is a common bone marrow disorder. This lecture will focus on the clinical and laboratory features of MDS as well as the classification, risk stratification, and prognosis of MDS. The current FDA-approved treatments will be discussed. Case studies will be utilized to help participants determine appropriate treatment for selected patients. Learn more.

DIC: A Case Study in APL

DIC is often a forgotten emergency in the oncology patient. This session is a comprehensive review of the coagulation cascade, physiology of DIC and Acute Leukemia. It evaluates the subset of patients at highest risk for DIC and provide illustrations of the clinical presentation of Acute Leukemia including pathophysiology, current treatment modalities and nursing strategies for management. Learn more.


What's Blasting Off in CML - Part 1 reviews the history, epidemiology, and pathophysiology of CML.  This section looks at how the Philadelphia Chromosome and associated genetic mutation helps separate CML from other leukemias.  Through the use of a case study, the usual patient presentation and diagnostic techniques in CML are reviewed.  Finally, the phases of CML as well as the clinical course associated with those phases are described.  Speakers for this podcast are Jill E. Nelson, APRN, BC, AOCNP® and Patricia Jakel, RN, MN, AOCN®.  This podcast is worth 0.5 CNE credits.

What's Blasting Off in CML - Part 2 discusses the management of CML in detail.  Questions related to past, present, and future therapies of CML are answered.  Resistance to standard imatinib therapy is explained and available alternate treatments are reviewed.  Clinical trial data for imatinib, dasatinib, and nilotinib are described as well as the common side effects seen with each therapy.  The speaker for this podcast is Michael J. Mauro, MD.  This podcast is worth 0.75 CNE credits.

What's Blasting Off in CML - Part 3 discusses patient adherence to therapy. The failure of patients to take their medications as prescribed can have dramatic effects, most importantly, can contribute to treatment failure.  This section reviews data on the high incidence of patient nonadherence to oral therapies and encourages nurses to actively evaluate their patients’ adherence to therapy.   This section concludes with a case study and a Q & A session from the Satellite Symposium.  The speakers for this podcast are Patricia Jakel, RN, MN, AOCN® and other faculty for Q & A portion.  This podcast is worth 0.3 CNE credits.

Download these three exciting podcasts now.